We found that the downregulation of METTL1 led to decreased m7G level and overexpression of METTL1 led to increased m7G level (Fig. 4H) showing that METTL1 was exactly a m7G writer in bladder cancer. This evidence concerns the gene METTL1 and urinary bladder carcinoma.